Last reviewed · How we verify
Montmorrillonite
At a glance
| Generic name | Montmorrillonite |
|---|---|
| Also known as | Montmorrillonite Powder |
| Sponsor | Chinese Medical Association |
| Modality | Small molecule |
| Therapeutic area | Other |
| Phase | FDA-approved |
Approved indications
Common side effects
Key clinical trials
- INSTRUMENT ASSISSTED SOFT TISSUE MOBILIZATION VERSUS DRY CUPPING ON UPPER TRAPEZIUS TRIGGER POINTS: A RANDOMIZED CONTROLLED TRIAL (NA)
- Impact of the Inno Cleanse Dietary Supplement on Gut Health and Associated Variables in Healthy Men and Women (NA)
- A Study Comparing Peloid Therapy and Hot Pack Treatment in Adults With Chronic Low Back Pain Caused by Lumbar Disc Herniation (NA)
- Assessing the Clinical Efficacy of Bentonite Clay Gel on Bone Regeneration in the Treatment of Intra-bony Defects: A Clinico-radiograph Study (NA)
- A Multicenter, Prospective Study of Diarrhea Tolerance of Pyrotinib Combined With Trastumab and Taxane in the First-line Treatment of HER2-positive Advanced Breast Cancer (PHASE2)
- A Clinical Study of Darcilil Combined With AI Combined With Pyrrotinib in the Treatment of TPBC (NA)
- Effect of Montmorillonite Power or Loperamide on the Pharmacokinetics of Pyrotinib in Healthy Subjects (PHASE1)
- The Cosmetic Effect of Mineral Clay Masks (NA)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Montmorrillonite CI brief — competitive landscape report
- Montmorrillonite updates RSS · CI watch RSS
- Chinese Medical Association portfolio CI